| Literature DB >> 3700686 |
Abstract
Critical questions remain concerning many issues involved in the identification of bioequivalent and therapeutically equivalent drugs. They need to be answered, and scientists and clinicians should address these issues, in concert with the FDA, as soon as possible.Mesh：
Substances：
Year: 1986 PMID： 3700686 DOI： 10.1002/j.1552-4604.1986.tb03531.x
Source DB: PubMed Journal: J Clin Pharmacol ISSN： 0091-2700 Impact factor: 3.126